iHuman (IH)
NYSE:IH
Want to see IH full AI Analyst Report?
IH Stock Chart & Stats
$2.00
-$0.07(-4.34%)
At close: 4:00 PM EST
$2.00
-$0.07(-4.34%)
Day’s Range― - ―
52-Week Range$1.33 - $3.60
Previous CloseN/A
Volume8.51K
Average Volume (3M)17.50K
Market Cap
$73.60M
Enterprise Value-$1.02B
Total Cash (Recent Filing)$1.10B
Total Debt (Recent Filing)$12.28M
Price to Earnings (P/E)1.0
Beta0.36
Next Earnings
Jun 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.93%
Share Statistics
EPS (TTM)10.58
Shares Outstanding22,312,862
10 Day Avg. Volume15,971
30 Day Avg. Volume17,505
Financial Highlights & Ratios
PEG Ratio-0.50
Price to Book (P/B)0.15
Price to Sales (P/S)0.19
P/FCF Ratio3.34
Enterprise Value/Market Cap-13.93
Enterprise Value/Revenue-1.16
Enterprise Value/Gross Profit-1.71
Enterprise Value/Ebitda-13.36
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthiHuman's extremely low leverage and large equity base provide durable financial flexibility. This reduces refinancing and solvency risk, supports continued R&D and product investment during downturns, and preserves optionality for M&A or buybacks over the next 2–6 months.
High Gross Margins And ProfitabilityConsistently high gross margins imply strong unit economics from digital learning products. Maintaining positive net margins despite revenue softness demonstrates disciplined cost control and sustainable pricing power, which support long-term margin resilience and reinvestment capacity.
AI Product Expansion & Leadership HiresAcquisitions and senior hires expand iHuman's AI capabilities and product breadth beyond preschool content, enhancing addressable market and product differentiation. Institutional valuation and board approval signal strategic intent to scale AI-native offerings and extend user lifecycles.
Bears Say
Revenue ContractionSustained top-line declines erode scale advantages and reduce margins over time. Falling revenue constrains marketing and product investment, weakens competitive positioning versus larger rivals, and makes profit maintenance dependent on continued cost cuts rather than organic growth.
Deteriorating Cash ConversionMaterial decline in operating and free cash flow reduces financial headroom for product development, marketing, or acquisitions. Weaker cash conversion increases sensitivity to working-capital swings and limits the firm's ability to fund strategic initiatives without drawing on reserves.
Structural Market HeadwindsDemographic decline and softer consumer spending directly compress the core early-childhood market over the medium term. This structural pressure raises customer acquisition costs, shortens lifetime value potential, and forces greater reliance on diversification to sustain growth.
iHuman News
IH FAQ
What was iHuman’s price range in the past 12 months?
iHuman lowest stock price was $1.33 and its highest was $3.60 in the past 12 months.
What is iHuman’s market cap?
iHuman’s market cap is $73.60M.
When is iHuman’s upcoming earnings report date?
iHuman’s upcoming earnings report date is Jun 24, 2026 which is in 14 days.
How were iHuman’s earnings last quarter?
iHuman released its earnings results on Mar 31, 2026. The company reported $0.041 earnings per share for the quarter, beating the consensus estimate of N/A by $0.041.
Is iHuman overvalued?
According to Wall Street analysts iHuman’s price is currently Overvalued.
Does iHuman pay dividends?
iHuman pays a Annually dividend of $0.085 which represents an annual dividend yield of 3.93%. See more information on iHuman dividends here
What is iHuman’s EPS estimate?
iHuman’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does iHuman have?
iHuman has 22,312,862 shares outstanding.
What happened to iHuman’s price movement after its last earnings report?
iHuman reported an EPS of $0.041 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.437%.
Which hedge fund is a major shareholder of iHuman?
Currently, no hedge funds are holding shares in IH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
iHuman
Operating within the People's Republic of China, iHuman Inc. specializes in delivering educational resources aimed at fostering cognitive growth. Their offerings reach a broad audience, encompassing individual consumers, early learning institutions, and wholesale distributors. A significant portion of their portfolio consists of interactive and self-guided digital applications. These include popular titles such as iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, and iHuman Readers. Beyond digital platforms, iHuman Inc. also furnishes a diverse array of physical educational content, ranging from books and interactive tools to smart devices. These resources are specifically designed to cultivate essential childhood skills, such as verbal communication, analytical reasoning, autonomous reading, and creative expression. Established in 1996, the company maintains its headquarters in Beijing, located within the People's Republic of China.
Technical Analysis
China Online Education Group
―
Sunlands Online Education Group
―
Skillsoft
―
Classover Holdings
―
Genius Group Limited
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.09% Other Institutional Investors
99.91% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---